Last updated: May 29, 2024
Sponsor: Peking University Third Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cancer
Treatment
Chinese traditional medicine nursing combined with case tracking management
Health Education
Clinical Study ID
NCT06441513
LM2023104
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- (1) no HFS symptoms in chemotherapy patients; (2) Ages 18 to 65 years; (3) Estimatedsurvival ≥ 3 months; (4) There was no dysfunction of major organs, heart, liver andkidney functions were basically normal, and the laboratory indicators met thefollowing requirements: neutrophils > 1.5 × 109/l, platelets > 100 × 109/l,hemoglobin > 90g/l; Bilirubin was normal or < 1.5 × ULN; AST and alt < 2.5 × ULN;Serum creatinine < 1.5 × ULN; Endogenous creatinine clearance (CCR) ≥ 60ml/min. (5)Those who can understand the situation of this study, can cooperate in theassessment of HFS grading, and have signed the informed consent.
Exclusion
Exclusion Criteria:
- (1) history of nerve trauma before chemotherapy, diabetic neuropathy, spinal cordcompression syndrome without surgical treatment, spinal canal stenosis or spinalcord nerve root compression, and central nervous system tumors; (2) Patients withskin lesions of hands and feet; (3) Those who have plans to use other drugs that mayaffect HFS (including urea cream, vitamin B6, celecoxib, compound Sophora flavescensinjection, calf blood deproteinized extract intravenous injection); (4) Patientswith severe, uncontrolled organic lesions or infections, such as decompensatedheart, lung, renal failure, etc., that lead to intolerance to chemotherapy; (5)Those who participate in other clinical trials at present or within 4 weeks; (6)Obvious neurological and psychiatric history, including dementia or epilepsy thatmay affect understanding and informed consent; (7) Intolerant or allergic to thetraditional Chinese medicine prescriptions in this study.
Study Design
Total Participants: 130
Treatment Group(s): 2
Primary Treatment: Chinese traditional medicine nursing combined with case tracking management
Phase:
Study Start date:
January 01, 2021
Estimated Completion Date:
July 01, 2024
Study Description
Connect with a study center
Peking University Third Hospital
Beijing, Beijing
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.